Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Movers
  • News

What’s Going On With Canopy Growth Stock Today?

By Erica Kollmann
April 1, 2:00 PM
Canopy Growth shares are trading lower Monday after the company announced Institutional Shareholder Services (ISS) has recommended that Canopy shareholders vote to approve the creation of exchangeable shares to further the advancement of Canopy USA. 

CGC

Read More
3 minute read
  • Cannabis
  • Eurozone
  • Government
  • Legal
  • News
  • Politics
  • Regulations

Here’s What You Need To Know About Weed Legalization In Germany That Just Took Effect

By Jelena Martinovic
April 1, 10:06 AM
German legalization will one of the many hot topics at the Benzinga Cannabis Capital Conference in Florida on April 16-17.

ACB

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Retail Sales

Cannabis Company AYR Wellness Launches Gluten-Free Vegan Edibles, Targets $2B Market

By Nicolas Jose Rodriguez
March 30, 10:54 AM
Cannabis Company AYR Wellness Inc. (OTC: AYRWF) launched its Kynd brand's premium edibles in Florida and Nevada, emphasizing natural flavors and vegan gluten-free options. 

AYRWF

Read More
3 minute read
  • Biotech
  • Cannabis
  • News
  • Psychedelics

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

By Lara Goldstein
March 30, 8:57 AM
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two…

CMND

Read More
2 minute read
  • Cannabis
  • Markets
  • Movers

Marijuana Stock Movers For March 29, 2024

By Benzinga Insights
March 29, 4:30 PM
GAINERS: GreenGro Technologies (OTC:GRNH) shares closed up 9900.00% at $0.0001 CordovaCann (OTC:LVRLF) shares closed up 97.16% at $0.09…

ACB

Read More
4 minute read
  • Biotech
  • Cannabis
  • Financing
  • Legal
  • Management
  • Psychedelics

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence

By Lara Goldstein
March 29, 12:43 PM
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have…

ATAI

Read More
4 minute read
  • Cannabis
  • Cryptocurrency
  • Entertainment
  • Exclusives
  • Global
  • Tech
  • Top Stories
  • Trading Ideas

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet

By Chris Katje
March 29, 10:01 AM
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.

AMC

Read More
4 minute read
  • Biotech
  • Cannabis
  • Earnings
  • Psychedelics

Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline

By Lara Goldstein
March 29, 9:20 AM
Clinical-stage psychedelics biotech Atai Life Sciences (NASDAQ:ATAI) announced its consolidated financial results for the fourth quarter and full…

ATAI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Exclusives
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Retail Sales

California’s Weed Sales Decline: Market Ripe For Consolidation, Biggest Companies Likely To Benefit

By Nicolas Jose Rodriguez
March 29, 8:48 AM
The California cannabis sector is facing a sales decline, according to a recent market update from Pablo Zuanic, senior equity research analyst at Zuanic & Associates.

GHBWF

Read More
2 minute read
  • Cannabis
  • News
  • Offerings

Canadian Cannabis Giant Sets Stage For Growth With $18.5M Public Offering

By Patricio Liddle
March 29, 8:15 AM
Discover OrganiGram's strategic $25M public offering aimed at fueling growth and shaping the future of the cannabis industry.

OGI

Posts pagination

Previous 1 … 43 44 45 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service